Loading
Busque productos, empresas, pruebas y guías: pase de la consulta a la solicitud de cotización en un solo lugar.
Pruebas
The determination of the ratio of the myeloid-derived suppressor cells to total non-granulocytic leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.
Artículo
Research record from Zhonghua Xue Ye Xue Za Zhi, 2026-07-01. PMID 42706170.
Pruebas
A BCR-ABL1 genetic test uses a sample of blood or bone marrow to look for an abnormal gene called BCR-ABL1. This abnormal gene is found in certain types of blood cancer , such as chronic myeloid leukemia (CML).
Indicadores
A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active tyrosine kinase activity. This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic leukemia.
Pruebas
The determination of the amount of CD33 expressing cells per unit present in a sample.
Indicadores
This gene plays a role in body weight homeostasis and cellular proliferation. Mutations in the gene are associated with acute myeloid leukemia.
Artículo
Research record from Curr Oncol, 2026-08-25. PMID 42782852.
Pruebas
The determination of the amount of CCL23, chemokine (C-C motif) ligand 23, present in a sample.
Pruebas
The determination of the ratio of monocytes classic to myeloid cells present in a sample. The measurement may be expressed as a ratio or percentage.
Pruebas
The determination of the ratio of dendritic cells to myeloid cells present in a sample. The measurement may be expressed as a ratio or percentage.
Artículo
Research record from Clin Chim Acta, 2026-08-20. PMID 42624191.
Pruebas
The determination of the amount of double-negative myeloid dendritic cells (any myeloid dendritic cell that is both CD1c-CD141-) present in a sample.
